Not all sufferers with CLL require therapy. Inspite of all latest advances, the iwCLL nevertheless suggests watchful observation for patients with asymptomatic illness.86 This suggestion relies on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). adalah situs judi on the net https://buzzr123fdz1.ourabilitywiki.com/user